Physician profile
William R Mitchell
NPI 1811949308
$26,146.96
in general payments reported to CMS, 2019-2025
95 companies · $2,772 in 2025
The $2,772 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,834 · 2020: $4,928 · 2021: $5,951 · 2022: $3,630 · 2023: $2,458 · 2024: $1,574 · 2025: $2,772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,563 · Long Term Medical Supply Or Device Loan: $167 · Education: $74.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,563.27 |
| Long Term Medical Supply Or Device Loan | $166.66 |
| Education | $74.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Secura Bio, INC. | $4,187.33 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $4,162.53 | 2019-2025 | |
| Genzyme Corporation | $1,723.88 | 2019-2025 | |
| Epizyme, INC. | $1,366.28 | 2020-2022 | |
| Kite Pharma, INC. | $1,196.20 | 2020-2025 | Yescarta |
| Genentech USA, INC. | $864.02 | 2019-2025 | Lunsumio, Polivy, Venclexta |
| Beigene USA, INC. | $741.09 | 2021-2023 | Brukinsa |
| Astrazeneca Pharmaceuticals Lp | $725.60 | 2019-2025 | Enhertu, Calquence, Lynparza |
| E.R. Squibb & Sons, L.L.C. | $641.12 | 2019-2025 | Opdivo |
| Janssen Biotech, INC. | $641.07 | 2019-2025 | Tecvayli, Talvey, Darzalex |
| Incyte Corporation | $608.65 | 2019-2025 | Jakafi, Niktimvo |
| Pfizer INC. | $603.54 | 2019-2025 | |
| Exelixis INC. | $474.35 | 2019-2025 | Cabometyx |
| Glaxosmithkline, LLC. | $390.87 | 2020-2025 | Ojjaara, Jemperli, Zejula |
| Lilly USA, LLC | $388.04 | 2019-2025 | Verzenio, Jaypirca |
Show all 92 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $373.18 | 2019-2025 | Xospata, Vyloy, Padcev |
| Eisai INC. | $345.18 | 2020-2025 | |
| Karyopharm Therapeutics INC. | $340.18 | 2020-2025 | Xpovio |
| Amgen INC. | $334.90 | 2019-2024 | Lumakras, Xgeva, Nplate |
| Abbvie INC. | $321.98 | 2019-2025 | |
| Celgene Corporation | $317.51 | 2021-2025 | Pomalyst, Reblozyl, Opdivo |
| Daiichi Sankyo INC. | $263.54 | 2019-2025 | Enhertu, Injectafer |
| Merck Sharp & Dohme LLC | $260.77 | 2019-2025 | Keytruda, Welireg, Reblozyl |
| Takeda Pharmaceuticals U.S.A., INC. | $241.74 | 2019-2025 | Fruzaqla, Ninlaro, Iclusig |
| Cardinal Health 108 LLC | $236.11 | 2019 | |
| Array Biopharma INC | $234.77 | 2020-2025 | Braftovi, Mektovi, Lorbrena |
| Seagen INC. | $231.17 | 2019-2022 | |
| Gilead Sciences, INC. | $220.13 | 2021-2025 | Trodelvy |
| Adc Therapeutics America, INC. | $216.95 | 2022-2025 | |
| Cti Biopharma Corp. | $174.06 | 2023 | Vonjo |
| Pharmaessentia USA Corporation | $174.03 | 2022-2025 | Besremi |
| Sobi, INC | $168.11 | 2022-2025 | |
| Stemline Therapeutics INC. | $158.53 | 2023-2024 | Orserdu, Elzonris |
| Servier Pharmaceuticals LLC | $135.34 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.33 | 2020-2025 | Gilotrif |
| Apellis Pharmaceuticals, INC. | $120.32 | 2023 | Empaveli |
| Foundation Medicine, INC. | $101.29 | 2023 | |
| Emd Serono, INC. | $99.67 | 2020-2024 | Bavencio |
| Kyowa Kirin, INC. | $95.28 | 2019-2021 | |
| Pharmacyclics LLC, An Abbvie Company | $93.04 | 2019-2023 | Imbruvica |
| Pharmacosmos Therapeutics INC. | $92.39 | 2024-2025 | Monoferric, Cosela |
| Bayer Healthcare Pharmaceuticals INC. | $91.85 | 2019-2025 | |
| Deciphera Pharmaceuticals INC. | $90.34 | 2021-2025 | Qinlock, Romvimza |
| Jazz Pharmaceuticals INC. | $85.59 | 2019-2025 | |
| Rigel Pharmaceuticals, INC. | $83.77 | 2019-2023 | Tavalisse, Rezlidhia |
| Ipsen Biopharmaceuticals, INC | $78.51 | 2019-2023 | Somatuline Depot, Onivyde |
| Adaptive Biotechnologies Corporation | $69.76 | 2023-2025 | Clonoseq |
| Alnylam Pharmaceuticals INC. | $67.93 | 2023-2025 | Givlaari |
| Mirati Therapeutics, INC. | $65.09 | 2023-2024 | Krazati |
| Taiho Oncology, INC. | $63.57 | 2019-2021 | |
| Tersera Therapeutics LLC | $60.99 | 2020-2025 | Quzyttir, Xermelo |
| Beone Medicines USA, INC. | $55.52 | 2025 | Brukinsa |
| Janssen Pharmaceuticals, INC | $50.54 | 2019-2023 | Xarelto |
| Alexion Pharmaceuticals, INC. | $49.32 | 2019-2024 | Ultomiris |
| Dova Pharmaceuticals | $49.13 | 2019-2021 | |
| Springworks Therapeutics, INC. | $47.72 | 2024 | Ogsiveo |
| Morphosys, US INC. | $43.91 | 2021 | |
| Genmab U.S., INC. | $41.02 | 2023-2025 | Epkinly |
| G1 Therapeutics, INC. | $40.15 | 2022-2023 | Cosela |
| Shield Therapeutics INC | $38.36 | 2024-2025 | |
| Octapharma USA, INC. | $36.47 | 2024-2025 | Panzyga |
| Agios Pharmaceuticals, INC. | $34.94 | 2019-2025 | Pyrukynd |
| Tempus Ai, INC | $34.35 | 2025 | Xt Cdx |
| Cumberland Pharmaceuticals, INC. | $34.34 | 2025 | Sancuso |
| Recordati_rare_diseases_inc. | $34.10 | 2025 | Enjaymo |
| Fresenius Kabi USA, LLC | $33.16 | 2024 | Stimufend |
| Acrotech Biopharma INC. | $30.76 | 2021 | |
| Coherus Oncology, INC. | $29.55 | 2021-2022 | |
| Legend Biotech USA INC. | $29.41 | 2025 | Carvykti |
| Heron Therapeutics, INC. | $27.82 | 2021 | |
| Myovant Sciences INC. | $27.54 | 2021 | |
| Global Blood Therapeutics, INC. | $26.86 | 2021 | |
| Geron Corporation | $26.39 | 2025 | Rytelo |
| Tolmar Pharmaceuticals, INC. | $25.02 | 2019 | |
| Caris Mpi, INC. | $24.24 | 2025 | Mi Cancer Seek |
| Amneal Pharmaceuticals LLC | $24.00 | 2025 | Alymsys |
| Immunogen, INC. | $23.88 | 2023 | Elahere |
| Accord Healthcare, INC. | $22.42 | 2025 | |
| Avyxa Pharma, LLC | $22.27 | 2025 | |
| Partner Therapeutics, INC. | $21.77 | 2019 | |
| Azurity Pharmaceuticals, INC. | $21.48 | 2024 | Vivimusta |
| Iovance Biotherapeutics, INC. | $21.08 | 2025 | Amtagvi |
| Spectrum Pharmaceuticals INC. | $20.61 | 2023 | Rolvedon |
| Mylan Institutional INC. | $20.34 | 2019 | |
| Menarini Silicon Biosystems, INC. | $18.34 | 2025 | |
| Sun Pharmaceutical Industries INC. | $18.17 | 2019 | |
| Puma Biotechnology, INC. | $17.24 | 2021 | |
| Tg Therapeutics, INC. | $17.05 | 2021 | |
| Verastem, INC. | $14.72 | 2019 | |
| Novocure INC. | $14.70 | 2019 | |
| Aveo Pharmaceuticals, INC. | $13.39 | 2022 | |
| Immunomedics, INC. | $11.41 | 2020 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
Vonjo $232Enhertu $214Braftovi $205Venclexta $202Lenvima $201Jakafi $188Mektovi $186Tecvayli $178Kisqali $170Besremi $153Sarclisa $149Talvey $143Opdivo $142Lorbrena $137Pomalyst $136Ojjaara $127Cabometyx $127Tukysa $106Niktimvo $106Ibrance $104Lutathera $101Xpovio $92.22Padcev $85.44Orserdu $83.26Tibsovo $80.86Brukinsa $77.33Darzalex $77.05Reblozyl $76.16Elzonris $75.27Bosulif $74.12Monoferric $73.56Elrexfio $72.31Lunsumio $72.28Carvykti $71.99Keytruda $71.67Clonoseq $69.76Givlaari $67.93Calquence $66.40Krazati $65.09Bavencio $64.18Lynparza $64.09Verzenio $62.31Jaypirca $62.31Xofigo $62.22Nubeqa $62.22Jemperli $61.82Zejula $61.82Pluvicto $60.66Empaveli $60.61Polivy $60.24Epkinly $57.82Imbruvica $54.86Columvi $50.01Ogsiveo $47.72Besponsa $47.64Fruzaqla $46.74Lumakras $46.68Injectafer $46.58Imfinzi $46.41Vectibix $46.07Nplate $46.07Xgeva $46.07Inlyta $44.79Rybrevant $43.76Cosela $42.76Yescarta $41.76Ninlaro $41.12Emrelis $40.43Tecentriq $39.85Gilotrif $39.60Accrufer $38.36Xarelto $37.30Idhifa $36.71Trodelvy $36.48Panzyga $36.47Xtandi $35.93Fabhalta $35.49Zynlonta $34.65Adcetris $34.49Xt Cdx $34.35Sancuso $34.34Enjaymo $34.10Iclusig $33.88Stimufend $33.16Doptelet $32.07Blenrep $30.47Synagis $30.01Kyprolis $27.87Blincyto $27.87Prolia $27.59Evenity $27.59Rytelo $26.39Quzyttir $25.39Ziihera $25.21Welireg $24.74Mi Cancer Seek $24.24Somatuline Depot $24.18Onivyde $24.18Qinlock $24.13Romvimza $24.13
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.